Posted on May 19, 20215/19/21
Nevada’s Drug Price Transparency Bill Up for Permanent Funding
Posted on May 18, 20215/18/21
TLV Suggests Access to National Health Data Registers Could Help Enable Follow-up Care
Posted on May 17, 20215/17/21
Last Week in Review: 5/10/2021 – 5/14/2021
Posted on May 11, 20215/11/21
China’s 5th Round of VBP Officially Covers 60 Drugs, 202 Specifications, Says Joint Procurement Office Notice
Posted on May 6, 20215/6/21
ZIN Rejects Kaftrio Plus Kalydeco, Urges 75% Price Reduction and Renegotiation of All Vertex Drugs
Posted on May 5, 20215/5/21
NICE Extends Clinical Eligibility Criteria for Spinraza
Posted on May 4, 20215/4/21
EFPIA Report Highlights 6 Core Principles to Govern Transparency in Evidence Under Novel Pricing Agreements
Posted on April 28, 20214/28/21